Woonsocket Call
Biogen tabs veteran pharma leader Viehbacher as next CEO
Providence County
•
Nov 10, 2022
Biogen
Latest Rhode Island stories tagged “Biogen”.
Woonsocket Call
Pawtucket Times
Alzheimer's drug shows promise in early results of study
Providence County
•
Sep 28, 2022
Woonsocket Call
Alzheimer's drug shows promise in early results of study
Providence County
•
Sep 28, 2022
Woonsocket Call
Biogen pays $900M to settle doctor kickback allegations
Providence County
•
Sep 27, 2022
Woonsocket Call
Biogen chops expenses in Q2, raises 2022 profit forecast
Providence County
•
Jul 20, 2022
Go Local Prov
Brown's Salloway Responds to GoLocal Article on Alzheimer's Drug Failure
Rhode Island
•
May 5, 2022
Woonsocket Call
Change at the top for Biogen after Alzheimer's drug flops
Providence County
•
May 3, 2022
Woonsocket Call
Biogen's 2022 outlook leaves investors wanting, shares slip
Providence County
•
Feb 3, 2022
Pawtucket Times
Biogen's 2022 outlook leaves investors wanting, shares slip
Providence County
•
Feb 3, 2022
Woonsocket Call
Biogen tumbles after Medicare lays out Aduhelm coverage plan
Providence County
•
Jan 12, 2022
Woonsocket Call
Biogen CEO: 'Major bottleneck' still limits Alzheimer's drug
Providence County
•
Oct 20, 2021
Pawtucket Times
Biogen CEO: 'Major bottleneck' still limits Alzheimer's drug
Providence County
•
Oct 20, 2021
Daily Mail on Rhode Island
Biogen says uptake on new Alzheimer's drug slower than expected
Rhode Island Non-Local Sources
•
Jul 22, 2021
Daily Mail on Rhode Island
Biogen Alzheimer's drug slow to take off as U.S. Medicare wrestles with coverage
Rhode Island Non-Local Sources
•
Jul 21, 2021
Fox News on Rhode Island
Biogen's debated Alzheimer's drug given to first patient
Rhode Island Non-Local Sources
•
Jun 16, 2021
Daily Mail on Rhode Island
First patient set to receive controversial Biogen Alzheimer's drug
Rhode Island Non-Local Sources
•
Jun 16, 2021
Go Local Prov Business
UPDATED: FDA Gives Approval to Biogen's Alzheimer's Drug Aducanumab Which Has Deep RI Roots
Rhode Island Business
•
Jun 7, 2021
Go Local Prov
Biogen's Alzheimer's Drug Aducanumab Has Deep RI Roots, FDA Expected to Rule on Monday
Rhode Island
•
Jun 7, 2021
Pawtucket Times
Biogen agrees to pay $22M to settle kickback allegations
Providence County
•
Dec 17, 2020
Daily Mail on Rhode Island
U.S. experts to review Biogen drug that could be first new Alzheimer's treatment in decades
Rhode Island Non-Local Sources
•
Nov 3, 2020